Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

RAPID DOSE THERAPEUTICS ANNOUNCES GRANT OF INCENTIVE STOCK OPTIONS

July 30, 2021


BURLINGTON, Ontario July 30, 2021 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), announces, pursuant to its Stock Option Plan, the granting of incentive stock options to purchase 2,100,000 common shares at an exercise price of $0.65 per share. Each has a...

Rapid Dose Provides Bi-Weekly Status Report Regarding Management Cease Trade Order

July 27, 2021


TORONTO, ONTARIO, July 27, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) is providing a bi-weekly update on the status of the management cease trade order granted on  June 29, 2021 (the “MCTO”) by its principal regulator, the Ontario Securities Commission, in accordance...

Rapid Dose Therapeutics Announces the Appointment of Advisory Board

July 22, 2021


Rapid Dose Therapeutics Announces the Appointment of Advisory Board Ron Brooks, CPA, CA, ICD.D, Nick DiRenzo, FCA, FCPA, ICD.D and Anne Lachance, ICD.D appointed to help support the Company’s global expansion BURLINGTON, Ontario – July 22, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”)...

Rapid Dose Therapeutics and McMaster University Provide Update on COVID-19 Vaccine Research Collaboration with Orally Dissolvable QuickStrip™ Technology

July 20, 2021


Rapid Dose Therapeutics and McMaster University Enter Next Stage of COVID-19 QuickStrip™ Vaccine Research Ahead of Schedule Pre-clinical in vivo testing expected to prove efficacy of QuickStrip technology in the delivery of vaccines   BURLINGTON, Ontario – July 20, 2021- Rapid Dose Therapeutics Corp. (“RDT”...

Rapid Dose Provides Bi-Weekly Status Report Regarding Management Cease Trade Order and Update Regarding Interim Financial Statements

July 14, 2021


Rapid Dose Provides Bi-Weekly Status Report Regarding Management Cease Trade Order and Update Regarding Interim Financial Statements TORONTO, ONTARIO, July 13, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) is providing a bi-weekly update on the status of the management cease trade order...

Rapid Dose Therapeutics-Branded Cannabis Products in Retail Locations Across Canada Via Master Distribution Agreement with Namaste Technologies Subsidiary CannMart

July 13, 2021


Rapid Dose Therapeutics-Branded Cannabis Products in Retail Locations Across Canada Via Master Distribution Agreement with Namaste Technologies Subsidiary CannMart Rapid Dose Therapeutics Announces its Latest Innovation with the Launch of QuickSips™ Biodegradable Infused Straw BURLINGTON, Ontario – July 13, 2021- Rapid Dose Therapeutics Corp. (“RDT”...

Rapid Dose Granted Management Cease Trade Order

June 29, 2021


Rapid Dose Granted Management Cease Trade Order TORONTO, ONTARIO, June 29, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) announces that, further to its news release dated June 18, 2021, the Company’s principal regulator, the Ontario Securities Commission (the “OSC”) granted a management...

Rapid Dose Therapeutics and McMaster University Provide Update on COVID-19 Vaccine Research Collaboration with Orally Dissolvable QuickStrip™ Technology

June 23, 2021


The National Research Council of Canada provides the SARS-CoV-2 spike protein for the next phase of preclinical studies BURLINGTON, Ontario – June 23, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are pleased to announce that they have...

Rapid Dose Therapeutics Signs Exclusive Manufacturing And Distribution Agreement With Maplex Naturals Inc.

April 13, 2021


BURLINGTON, Ontario – April 13, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian Life Science company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film, infused with an active...

Rapid Dose Therapeutics Closes Purchase and Amalgamation of Consolidated Craft Brands

March 19, 2021


BURLINGTON, Ontario, March 19, 2021 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film infused with an...

1 2 3 4 5 6 7